Hydroxyurea with Thalidomide Combination therapy in a Rare Case of JAK2 mutation (JAK2V617F) and BCR–ABL Positive Myelofibrosis - Current Issue

Hydroxyurea with Thalidomide Combination therapy in a Rare Case of JAK2 mutation (JAK2V617F) and BCR–ABL Positive Myelofibrosis - Current Issue - IJSR